2min snip

Breakpoints cover image

#85 – Who You Gonna Call? Mythbusters! Antibiotic Myths for Infectious Diseases Clinicians

Breakpoints

NOTE

Science Unfolds: Rethinking Linazolid Use in Renal Dysfunction

Recent findings challenge the long-held belief that Linezolid does not require renal dose adjustment. Research highlighted the existence of active metabolites of Linezolid that accumulate in patients with renal dysfunction, potentially leading to an increased risk of thrombocytopenia. This relationship underscores the importance of monitoring and adjusting the dosage of Linezolid in these patients. Instead of discontinuing the drug altogether, therapeutic drug monitoring can allow for informed decisions, potentially enabling healthcare providers to reduce the dose effectively rather than ceasing its use. This shift in understanding demonstrates the value of ongoing scientific inquiry and its power to transform clinical practice.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode